Medium-dose losartan/hydrochlorothiazide vs maximal dose angiotensin receptor antagonists in patients with hypertension uncontrolled on medium-dose angiotensin receptor antagonists

Trial Profile

Medium-dose losartan/hydrochlorothiazide vs maximal dose angiotensin receptor antagonists in patients with hypertension uncontrolled on medium-dose angiotensin receptor antagonists

Completed
Phase of Trial: Phase III

Latest Information Update: 17 Mar 2013

At a glance

  • Drugs Losartan/hydrochlorothiazide (Primary) ; Angiotensin receptor antagonists
  • Indications Hypertension
  • Focus Therapeutic Use
  • Acronyms Kobe-CONNECT
  • Most Recent Events

    • 17 Mar 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top